Penumbra, Inc. (PEN)
NYSE: PEN · Real-Time Price · USD
334.17
-1.39 (-0.41%)
At close: Mar 24, 2026, 4:00 PM EDT
334.76
+0.59 (0.18%)
After-hours: Mar 24, 2026, 7:00 PM EDT
Penumbra Employees
Penumbra had 4,700 employees as of December 31, 2025. The number of employees increased by 200 or 4.44% compared to the previous year.
Employees
4,700
Change (1Y)
200
Growth (1Y)
4.44%
Revenue / Employee
$298,652
Profits / Employee
$37,806
Market Cap
13.11B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 4,700 | 200 | 4.44% |
| Dec 31, 2024 | 4,500 | 300 | 7.14% |
| Dec 31, 2023 | 4,200 | 300 | 7.69% |
| Dec 31, 2022 | 3,900 | 100 | 2.63% |
| Dec 31, 2021 | 3,800 | 500 | 15.15% |
| Dec 31, 2020 | 3,300 | 600 | 22.22% |
| Dec 31, 2019 | 2,700 | 500 | 22.73% |
| Dec 31, 2018 | 2,200 | 500 | 29.41% |
| Dec 31, 2017 | 1,700 | 200 | 13.33% |
| Dec 31, 2016 | 1,500 | 400 | 36.36% |
| Dec 31, 2015 | 1,100 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
| Company Name | Employees |
|---|---|
| Koninklijke Philips | 65,340 |
| Smith & Nephew | 18,060 |
| STERIS | 17,787 |
| Zimmer Biomet Holdings | 17,000 |
| DexCom | 11,100 |
| Bio-Rad Laboratories | 7,450 |
| Bio-Rad Laboratories | 7,450 |
| Globus Medical | 6,000 |
PEN News
- 14 days ago - 8 Stocks to Buy as Merger-Mania Takes Over - Benzinga
- 27 days ago - Penumbra, Inc. Reports Fourth Quarter and Full Year 2025 Financial Results - PRNewsWire
- 5 weeks ago - Allspring Growth Fund Q4 2025 Fund Performers And Detractors - Seeking Alpha
- 6 weeks ago - Boston Scientific announces results for fourth quarter and full year 2025 - PRNewsWire
- 2 months ago - Halper Sadeh LLC Encourages PEN and RAPT Shareholders to Contact the Firm to Discuss Their Rights - GlobeNewsWire
- 2 months ago - Artisan Small Cap Fund Q4 2025 Portfolio Activity - Seeking Alpha
- 2 months ago - Boston Scientific to buy Penumbra in $14.5B deal to expand cardiovascular reach - Invezz
- 2 months ago - Penumbra Stock Jumps. It's Being Bought by Boston Scientific for $14.5 Billion. - Barrons